| # | Drug | Count |
|---|---|---|
| 0 | RIVAROXABAN | 1708 |
| 1 | ASPIRIN | 1441 |
| 2 | ASPIRIN 325 MG | 1363 |
| 3 | ASPIRIN 81 MG | 1363 |
| 4 | APIXABAN | 1234 |
| 5 | CLOPIDOGREL | 1184 |
| 6 | WARFARIN | 1149 |
| 7 | FUROSEMIDE | 1018 |
| 8 | DABIGATRAN ETEXILATE | 857 |
| 9 | DABIGATRAN ETEXILATE MESYLATE | 836 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | APIXABAN | 1234 | 0.0181 |
| 1 | FONDAPARINUX SODIUM | 107 | 0.0132 |
| 2 | DABIGATRAN ETEXILATE MESYLATE | 836 | 0.0116 |
| 3 | DABIGATRAN ETEXILATE | 857 | 0.0111 |
| 4 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 43 | 0.0094 |
| 5 | ERGOCALCIFEROL | 277 | 0.0093 |
| 6 | WARFARIN | 1149 | 0.0090 |
| 7 | DASATINIB | 77 | 0.0083 |
| 8 | RIVAROXABAN | 1708 | 0.0082 |
| 9 | VANCOMYCIN HYDROCHLORIDE | 68 | 0.0081 |
| # | Drug class | Count |
|---|---|---|
| 0 | Factor Xa Inhibitor [EPC] | 2183 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1964 |
| 2 | Platelet Aggregation Inhibitor [EPC] | 1474 |
| 3 | Loop Diuretic [EPC] | 1137 |
| 4 | Corticosteroid [EPC] | 920 |
| 5 | Proton Pump Inhibitor [EPC] | 866 |
| 6 | P2Y12 Platelet Inhibitor [EPC] | 790 |
| 7 | HMG-CoA Reductase Inhibitor [EPC] | 715 |
| 8 | Benzodiazepine [EPC] | 714 |
| 9 | beta-Adrenergic Blocker [EPC] | 560 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Farnesyltransferase Inhibitor [EPC] | 1 | 0.0128 |
| 1 | Humanized Monoclonal Antibody Fragment [EPC] | 15 | 0.0105 |
| 2 | CD22-directed Immunoconjugate [EPC] | 31 | 0.0104 |
| 3 | Amyloid Beta-directed Antibody [EPC] | 32 | 0.0084 |
| 4 | Complement C5 Inhibitor [EPC] | 1 | 0.0083 |
| 5 | Carboxypeptidase [EPC] | 3 | 0.0083 |
| 6 | Factor Xa Inhibitor [EPC] | 2183 | 0.0079 |
| 7 | P2Y12 Platelet Inhibitor [EPC] | 790 | 0.0066 |
| 8 | CD33-directed Immunoconjugate [EPC] | 19 | 0.0052 |
| 9 | Phosphodiesterase 3 Inhibitor [EPC] | 32 | 0.0051 |